Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Cancer Letters|December 3, 2014
De novo hepatocellular carcinoma of liver allograft: a neglected issueFranco Trevisani, Francesca Garuti, Alessandro Cucchetti, et al.
Anti-Cancer Drugs|August 23, 2020
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible?Alessandro Di Federico, Giacomo Nuvola, Monia Sisi, et al.
Annals of Palliative Medicine|May 12, 2021
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (HCC) with orbital metastases: a case reportDaria M Filippini, Alessandro Di Federico, Barbara Lenzi, et al.
Anti-Cancer Drugs|March 4, 2021
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: a case report within the experience of a single institutionAlessandro Di Federico, Elisa Andrini, Monia Sisi, et al.
Cancers|December 11, 2022
The Palliative Prognostic (PaP) Score without Clinical Evaluation Predicts Early Mortality among Advanced NSCLC Patients Treated with ImmunotherapyAndrea De Giglio, Elisa Tassinari, Arianna Zappi, et al.
Frontiers in Immunology|December 8, 2025
Baseline neuronal antibodies in patients with small cell lung cancer are not necessarily associated with post-immune checkpoint inhibitors neurotoxicitiesSimone Rossi, Elisa Andrini, Rita Rinaldi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 11, 2012
QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosisFranco Trevisani, Antonio Di Micoli, Andrea Zambruni, et al.
Palliative & Supportive Care|February 19, 2026
Advance care planning knowledge, attitudes, and experiences among hospital healthcare professionals: A surveyAnna Giulia Macchiarelli, Emma Capulli, Rabih Chattat, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 18, 2018
Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal BleedingMaurizio Biselli, Annagiulia Gramenzi, Barbara Lenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 28, 2016
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinomaAnna Pecorelli, Barbara Lenzi, Annagiulia Gramenzi, et al.
Pageof 2